CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Contineum Therapeutics, Inc. (NASDAQ:CTNM) surges 10%; retail investors who own 51% shares profited along with institutions [Yahoo! Finance]
Contineum Therapeutics (NASDAQ:CTNM) was downgraded by analysts at Wall
Contineum Therapeutics (NASDAQ:CTNM) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $14.00 price target on the stock, down previously from $23.00.
Contineum Therapeutics (NASDAQ:CTNM) was upgraded by analysts at Wall St
Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
Form 144 Contineum Therapeutics, Filed by: Stengone Carmine N.
Form 4 Contineum Therapeutics, For: Feb 03 Filed by: Lorrain Daniel S.
Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
Form 4 Contineum Therapeutics, For: Jan 30 Filed by: Healy John Stephen
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.